摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[4-(3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoylamino]ethanesulfonic acid | 1808218-24-7

中文名称
——
中文别名
——
英文名称
2-[4-(3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoylamino]ethanesulfonic acid
英文别名
——
2-[4-(3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoylamino]ethanesulfonic acid化学式
CAS
1808218-24-7
化学式
C26H45NO6S
mdl
——
分子量
499.7
InChiKey
BHTRKEVKTKCXOH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    34
  • 可旋转键数:
    7
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.96
  • 拓扑面积:
    132
  • 氢给体数:
    4
  • 氢受体数:
    6

文献信息

  • Methods of treating SARS-COV-2 infections
    申请人:Tyme, Inc.
    公开号:US10905698B1
    公开(公告)日:2021-02-02
    The disclosure is directed to methods of using TUDCA, or a pharmaceutically acceptable salt thereof, or a derivative thereof, for the treatment of SARS-CoV-2 infections.
    本公开涉及使用 TUDCA 或其药学上可接受的盐或其衍生物治疗 SARS-CoV-2 感染的方法。
  • COMPOUND, ACTIVE LIGHT SENSITIVE OR RADIATION SENSITIVE RESIN COMPOSITION, RESIST FILM USING SAME, RESIST-COATED MASK BLANK, PHOTOMASK, PATTERN FORMING METHOD, METHOD FOR MANUFACTURING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE
    申请人:FUJIFILM Corporation
    公开号:US20160116840A1
    公开(公告)日:2016-04-28
    Provided is an active light sensitive or radiation sensitive resin composition which contains a compound (A) represented by General Formula (I) or (II): in the formulae, each of Y 1 and Y 2 represents a monovalent organic group; each of M 1 + and M 2 + represents an organic onium ion; each of X 1 and X 2 represents a group that is represented by —S—, —NH—, or —NR 1 —; R 1 represents a monovalent organic group; each of n1 and n2 represents an integer of 1 or more; and R 1 and Y 1 or Y 2 may bond with each other to form a ring.
  • METHODS OF TREATING SARS-COV-2 INFECTIONS
    申请人:Tyme, Inc.
    公开号:US20210353645A1
    公开(公告)日:2021-11-18
    The disclosure is directed to methods of using TUDCA, or a pharmaceutically acceptable salt thereof, or a derivative thereof, for the treatment of SARS-CoV-2 infections.
  • US9904167B2
    申请人:——
    公开号:US9904167B2
    公开(公告)日:2018-02-27
  • [EN] METHODS OF USING BILE ACIDS TO TREAT VIRAL INFECTIONS<br/>[FR] MÉTHODES D'UTILISATION D'ACIDES BILIAIRES POUR TRAITER DES INFECTIONS VIRALES
    申请人:HOFFMAN STEVEN
    公开号:WO2021231934A1
    公开(公告)日:2021-11-18
    The disclosure is directed to methods of using hydrophilic bile acids for the treatment of viral infections.
查看更多